Reference health

CD25 and indoleamine 2,3-dioxygenase are up-regulated by prostaglandin E2 and expressed by tumor-associated dendritic cells in vivo: additional mechanisms of T-cell inhibition

https://doi.org/10.1182/blood-2005-08-3507
CiteStamped reference-health badge
69/69 checkable references clean · checked 2026-07-22

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

2 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 69 checked references that resolve
resolves10.1146/annurev.immunol.21.120601.141135
Does the Immune System See Tumors as Foreign or Self?
resolves10.1126/science.7678351
Tumor Rejection After Direct Costimulation of CD8 <sup>+</sup> T Cells by B7-Transfected Melanoma Cells
resolves10.1073/pnas.92.18.8200
Follicular lymphomas can be induced to present alloantigen efficiently: a conceptual model to improve their tumor immunogenicity.
resolves10.4049/jimmunol.164.5.2285
TGF-β1 Reciprocally Controls Chemotaxis of Human Peripheral Blood Monocyte-Derived Dendritic Cells Via Chemokine Receptors
resolves10.4049/jimmunol.163.9.5020
T Cell-Derived IL-10 Promotes Lung Cancer Growth by Suppressing Both T Cell and APC Function
resolves10.1182/blood.V99.7.2468
CD4+ and CD8+ anergic T cells induced by interleukin-10–treated human dendritic cells display antigen-specific suppressor activity
resolves10.1038/nm1096-1096
Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells
resolves10.4049/jimmunol.159.1.28
IL-12-deficient dendritic cells, generated in the presence of prostaglandin E2, promote type 2 cytokine production in maturing human naive T helper cells
resolves10.4049/jimmunol.166.3.1650
Prostaglandin E2 Up-Regulates Macrophage-Derived Chemokine Production but Suppresses IFN-Inducible Protein-10 Production by APC
resolves10.1182/blood-2001-12-0360
Functionally distinct dendritic cell (DC) populations induced by physiologic stimuli: prostaglandin E2 regulates the migratory capacity of specific DC subsets
resolves10.1038/nri1498
Mechanisms and functional significance of tumour-induced dendritic-cell defects
resolves10.1006/cimm.1996.0140
Dendritic Cells in Antitumor Immune Responses
resolves10.1080/10428190500360971
Dendritic cells are significantly reduced in non-Hodgkin's lymphoma and express less CCR7 and CD62L
resolves10.1006/cimm.1996.0139
Dendritic Cells in Antitumor Immune Responses
resolves10.4049/jimmunol.159.10.4772
Induction of tolerance by IL-10-treated dendritic cells
resolves10.1038/nm976
Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells
resolves10.1038/nri1457
Ido expression by dendritic cells: tolerance and tryptophan catabolism
resolves10.1016/S0167-5699(99)01520-0
Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation?
resolves10.4049/jimmunol.168.8.3771
Cells Expressing Indoleamine 2,3-Dioxygenase Inhibit T Cell Responses
resolves10.1038/nm934
Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase
resolves10.1096/fasebj.5.11.1907934
Relationship between interferon‐γ, indoleamine 2,3‐dioxygenase, and tryptophan catabolism
resolves10.1126/science.281.5380.1191
Prevention of Allogeneic Fetal Rejection by Tryptophan Catabolism
resolves10.1038/nm1196
Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy
resolves10.1172/JCI21583
Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes
resolves10.4049/jimmunol.164.7.3596
Indoleamine 2,3-Dioxygenase Production by Human Dendritic Cells Results in the Inhibition of T Cell Proliferation
resolves10.1126/science.1073514
Potential Regulatory Function of Human Dendritic Cells Expressing Indoleamine 2,3-Dioxygenase
resolves10.4049/jimmunol.172.7.4100
Ligation of B7-1/B7-2 by Human CD4+ T Cells Triggers Indoleamine 2,3-Dioxygenase Activity in Dendritic Cells
resolves10.1084/jem.189.9.1363
Inhibition of  T Cell Proliferation by Macrophage Tryptophan Catabolism
resolves10.4049/jimmunol.169.4.1810
FcεRI Induces the Tryptophan Degradation Pathway Involved in Regulating T Cell Responses
resolves10.1084/jem.20020052
Inhibition of Allogeneic T Cell Proliferation by Indoleamine 2,3-Dioxygenase–expressing Dendritic Cells
resolves10.4049/jimmunol.165.3.1357
IFN-γ Inhibits Presentation of a Tumor/Self Peptide by CD8α− Dendritic Cells Via Potentiation of the CD8α+ Subset
resolves10.1189/jlb.72.6.1148
Monocyte-derived dendritic cells release neopterin
resolves10.1093/intimm/14.1.65
Functional expression of indoleamine 2,3-dioxygenase by murine CD8α+ dendritic cells
resolves10.4049/jimmunol.171.4.1652
Cutting Edge: Induced Indoleamine 2,3 Dioxygenase Expression in Dendritic Cell Subsets Suppresses T Cell Clonal Expansion
resolves10.1016/j.steroids.2004.05.019
Antigen-specific T cell functions are suppressed over the estrogen-dendritic cell-indoleamine 2,3-dioxygenase axis
resolves10.1182/blood-2005-03-0979
A two-step induction of indoleamine 2,3 dioxygenase (IDO) activity during dendritic-cell maturation
resolves10.4049/jimmunol.173.7.4352
Induction of a CD4+ T Regulatory Type 1 Response by Cyclooxygenase-2-Overexpressing Glioma
resolves10.4049/jimmunol.175.3.1483
Prostaglandin E2 Induces <i>FOXP3</i> Gene Expression and T Regulatory Cell Function in Human CD4+ T Cells
resolves10.1158/0008-5472.CAN-05-0141
Tumor Cyclooxygenase-2/Prostaglandin E2–Dependent Promotion of FOXP3 Expression and CD4+CD25+ T Regulatory Cell Activities in Lung Cancer
resolves10.1158/0008-5472.CAN-05-3252
Prostaglandin E2 Impairs CD4+ T Cell Activation by Inhibition of lck: Implications in Hodgkin's Lymphoma
resolves10.1074/jbc.M010787200
Overexpression of Cyclooxygenase-2 Is Sufficient to Induce Tumorigenesis in Transgenic Mice
resolves10.1172/JCI9621
Host cyclooxygenase-2 modulates carcinoma growth
resolves10.1016/S0092-8674(00)81433-6
Cyclooxygenase Regulates Angiogenesis Induced by Colon Cancer Cells
resolves10.1172/JCI16492
Cancer-associated immunodeficiency and dendritic cell abnormalities mediated by the prostaglandin EP2 receptor
resolves10.1146/annurev.bi.55.070186.000441
ARACHIDONIC ACID METABOLISM
resolves10.1093/jnci/90.20.1529
Cyclooxygenase-2 Inhibitors in Tumorigenesis (Part I)
resolves10.1016/S1470-2045(01)00488-0
Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer
resolves10.1126/science.1116221
Prostaglandin E <sub>2</sub> Promotes Colon Cancer Cell Growth Through a G <sub>s</sub> -Axin-ß-Catenin Signaling Axis
resolves10.1016/S1471-4906(01)02154-8
Prostaglandins as modulators of immunity
resolves10.1182/blood.V97.11.3466
Prostaglandin E2 is a selective inducer of interleukin-12 p40 (IL-12p40) production and an inhibitor of bioactive IL-12p70 heterodimer
resolves10.4049/jimmunol.168.5.2255
Cyclooxygenase-2-Issued Prostaglandin E2 Enhances the Production of Endogenous IL-10, Which Down-Regulates Dendritic Cell Functions
resolves10.1182/blood-2001-11-0017
Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells
resolves10.1182/blood-2003-05-1643
CCL19/CCL21-triggered signal transduction and migration of dendritic cells requires prostaglandin E2
resolves10.1002/eji.1830271209
Pro‐inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum‐free conditions
resolves10.1084/jem.179.4.1109
Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.
resolves10.1038/sj.tpj.6500240
Comparison of different isolation techniques prior gene expression profiling of blood derived cells: impact on physiological responses, on overall expression and the role of different cell types
resolves10.1074/jbc.M105517200
Major Histocompatibility Complex Class I-presented Antigenic Peptides Are Degraded in Cytosolic Extracts Primarily by Thimet Oligopeptidase
resolves10.4049/jimmunol.173.2.945
SHP-1 and SHP-2 Associate with Immunoreceptor Tyrosine-Based Switch Motif of Programmed Death 1 upon Primary Human T Cell Stimulation, but Only Receptor Ligation Prevents T Cell Activation
resolves10.4049/jimmunol.161.6.2804
Prostaglandin E2 Induces the Final Maturation of IL-12-Deficient CD1a+CD83+ Dendritic Cells: The Levels of IL-12 Are Determined During the Final Dendritic Cell Maturation and Are Resistant to Further Modulation
resolves10.4049/jimmunol.148.9.2845
Prostaglandin E2 and other cyclic AMP-elevating agents modulate IL-2 and IL-2R α gene expression at multiple levels
resolves10.1084/jem.183.4.1587
Metabolism of Tac (IL2Ralpha): physiology of cell surface shedding and renal catabolism, and suppression of catabolism by antibody binding.
resolves10.1016/1043-4666(90)90062-X
The molecular basis for the generation of the human soluble interleukin 2 receptor
resolves10.4049/jimmunol.131.2.690
Blockade of the interleukin-2 receptor by anti-Tac antibody: inhibition of human lymphocyte activation.
resolves10.4049/jimmunol.135.5.3172
Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro.
resolves10.3109/08820138909045783
Soluble Interleukin 2 Receptors Released from Mitogen Stimulated Human Peripheral Blood Lymphocytes Bind Interleukin 2 and Inhibit IL2 Dependent Cell Proliferation
resolves10.4049/jimmunol.165.11.6037
BDCA-2, BDCA-3, and BDCA-4: Three Markers for Distinct Subsets of Dendritic Cells in Human Peripheral Blood
resolves10.1002/(SICI)1097-0215(19971104)73:3<309::AID-IJC1>3.0.CO;2-3
Dendritic cells as mediators of tumor-induced tolerance in metastatic melanoma
resolves10.1093/intimm/10.2.237
Does the IL-2 receptor alpha chain induced on dendritic cells have a biological function?
resolves10.4049/jimmunol.161.10.5430
IL-2Rα on One Cell Can Present IL-2 to IL-2Rβ/γc on Another Cell to Augment IL-2 Signaling
The 2 references without a DOI — listed, not checked
no DOI — not checkedKobie JJ, Wu RS, Kurt RA, et al. Transforming growth factor beta inhibits the antigen-presenting functions and antitumor activity of dendritic cell vaccines. Cancer Res. 2003;63: 1860-1864.
no DOI — not checkedTroy AJ, Summers KL, Davidson PJ, Atkinson CH, Hart DN. Minimal recruitment and activation of dendritic cells within renal cell carcinoma. Clin Cancer Res. 1998;4: 585-593.
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-22 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1182/blood-2005-08-3507"><img src="https://citestamp.com/citestamped/10.1182/blood-2005-08-3507/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1182/blood-2005-08-3507/badge.svg)](https://citestamp.com/citestamped/10.1182/blood-2005-08-3507)